Compare LONA & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LONA | IH |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.7M | 58.8M |
| IPO Year | 2020 | 2020 |
| Metric | LONA | IH |
|---|---|---|
| Price | $4.35 | $1.16 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 82.9K | 2.1K |
| Earning Date | 11-17-2026 | 09-29-2026 |
| Dividend Yield | N/A | ★ 8.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.21 | $1.10 |
| 52 Week High | $14.21 | $2.99 |
| Indicator | LONA | IH |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 44.47 |
| Support Level | $4.39 | $1.10 |
| Resistance Level | $9.78 | $1.25 |
| Average True Range (ATR) | 0.45 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 2.87 | 28.57 |
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.